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Volume 56, Number 6 Abstracts 1827In direct comparison with small AAAs, medium (P  .39) and large (P 
.001) groups both required secondary intervention more frequently, with
hazard ratios of 2.32 (95% confidence interval, 1.045-5.156) and 4.74 (95%
confidence interval, 2.115-10.637), respectively. Overall 10-year survival
was 72% in the small, 63.1% in the medium, and 49.8% in the large group
(P  .001) with no known AAA-related deaths. Age-adjusted all-cause
mortality differed significantly among the group aged 75 to 84 years (30.4%
small, 51.6% medium, 55.7% large; P  .017).
Conclusions: EVAR for small AAAs demonstrates improved long-term
outcomes when compared with EVAR formedium and large AAAs. These data
suggest that EVAR for AAAs ranging from4 to 5 cmmay have better outcomes
than EVAR for age-matched patients with larger aneurysms.
Percutaneous Endovascular Repair of Juxtarenal Aortic Aneurysm
Using Customized Cook Zenith Fenestrated Stent Graft
Mateus P. Correa, Gustavo S. Oderich. Mayo Clinic, Rochester, Minn
Introduction: Fenestrated endovascular aortic repair (FEVAR) has
been used with increasing frequency to treat juxtarenal aortic aneurysms.We
present the preoperative planning, stent graft design, and technique of
implantation of a Cook Zenith (Cook Inc, Brisbane, Australia) customized
fenestrated stent graft in an 80-year-old woman with an enlarging 6-cm
juxtarenal aortic aneurysm.
Methods: Computed tomography angiography (CTA) with centerline
of flow analysis was used for measurements, and a customized stent graft was
designed with two 6-  8-mm renal artery fenestrations. Under general
anesthesia, bilateral percutaneous transfemoral access was established with
placement of preclosure sutures. After systemic heparinization, a 20F sheath
was introduced via the right transfemoral approach. The sheath valve was
punctured for placement of selective catheters to locate both renal arteries.
The Cook Zenith fenestrated component was oriented extracorporeally,
introduced, and deployed via the left transfemoral approach. The renal
arteries were accessed through the renal fenestrations, and 7F hydrophilic
sheaths were placed over 0.035-inch Rosen wires. A diameter-reducing wire,
which constrained the device, was removed, the uncovered stent was de-
ployed, and the top cap was retrieved. The proximal neck was balloon
dilated. Renal alignment stents were deployed and flared proximally using
10-mm angioplasty balloons. Selective renal arteriographies showed widely
patent renal arteries with no endoleak. The repair was completed with
deployment of a distal bifurcated component via the left transfemoral
approach and a right iliac limb extension. Completion angiography showed
widely patent target vessels, stent grafts, and iliac arteries without endoleak.
Total contrast volume was 62 mL, fluoroscopy was 40 minutes, and oper-
ating time was 82 minutes. The patient was dismissed home the next day
without complications, and a CTA showed no endoleak or stent graft
complications in 18 months of follow-up.
Conclusions: Customized fenestrated stent grafts have expanded the
indications of endovascular repair to include patients with inadequate infra-
renal aortic neck or involvement of the visceral arteries. The technique can
be performed using a total percutaneous approach and has the potential to
reduce mortality, morbidity, blood loss, operative time and hospital stay
compared with open surgical repair.
Long-Term Results for Endovascular Repair of Acute Complicated
Type B Aortic Dissection
Jennifer M. Hanna, Asvin Ganapathi, Nicholas Andersen, Richard L.
McCann, G. ChadHughes. DukeUniversityMedical Center, Durham, NC
Introduction: Despite the lack of current U.S. Food and Drug Ad-
ministration approval for management of acute complicated type B aortic
dissection, thoracic endovascular aortic repair (TEVAR) has replaced open
surgical management for this indication due to promising short-term and
midterm safety and efficacy. However, because of the relatively recent
adoption of this technology, long-term results with a view towards durability
and requirement for secondary procedures are limited. As such, the objective
of this study is to report long-term outcomes of TEVAR for acute (2 weeks
from symptom onset) complicated type B dissection.
Methods: Between July 2005 and June 2012, 47 patients underwent
TEVAR for the management of acute complicated type B dissection at a
single referral institution (Table I). Indications for intervention included
rupture in eight (17%), malperfusion in 23 (49%), and/or refractory pain or
hypertension in 18 (38%; Table II). Fisher exact t test was used to compare
continuous variables, and 2 test was used to compare categoric variables. A
Kaplan-Meier analysis with a log-rank test was used to compare aortic vs
overall survival.
Results: Primary technical success was 100%. In-hospital/30-day rates
of death, stroke, permanent paraplegia/paraparesis, and new dialysis were
0%, 2% (n 1), 2% (n 1), and 4% (n 2), respectively. Overall survival was
83% at 84 months, with none of the late deaths attributable to the aortic
pathology (Fig). The composite reintervention rate related to the index
procedure was 28% (n 13). Median time to reintervention was 4.5 months
(interquartile range, 1.4-8.1 months; Table III).
D
dConclusions: In the largest reported series with the longest follow-up
o date, the current results confirm the excellent short-term outcomes
f TEVAR for acute complicated type B dissection and further demonstrate
hat these results are durable over the long-term as well. The data support
he continued use of TEVAR for acute complicated type B aortic dissection.
able 1. Demographic characteristics and associated comorbidities
ariable
Thoracic endovascular aortic
repair (N47)
edian age (IQR), years 59.0 (53.5-70.5)
ale gender 34 (72%)
edian BMI (IQR) 28.3 (25.1-31.1)
arfan syndrome 4 (9%)
yperlipidemia 22 (47%)
rior aortic surgery 11 (23%)
iabetes mellitus 5 (11%)
istory of hypertension 43 (91%)
obacco use 25 (53%)
hronic obstructive pulmonary disease 6 (13%)
enal insufficiency (cr1.5) 17 (36%)
istory of stroke/TIA 3 (6%)
oronary artery disease 8 (17%)
QR, Interquartile range; BMI, body mass index; Cr, creatinine; TIA,
ransient ischemic attack
able 2. Clinical and radiographic characteristics on admission
ariable
Thoracic endovascular
aortic repair (N47)
BP on admission, mean  SD, mm Hg 156  37
BP on admission, mean  SD, mm Hg 76  22
ypotension/shock on admission 2 (4%)
linical or radiographic malperfusion on
admission
23 (49%)
Visceral malperfusion 11 (23%)
Renal malperfusion 10 (21%)
Iliofemoral malperfusion 12 (26%)
Spinal malperfusion 2 (4%)
resenting aortic symptoms 44 (94%)
Back pain 33 (70%)
Anterior chest pain 22 (47%)
efractory pain/hypertension 18 (38%)
upture 8 (17%)
iameter of descending aorta, mean  SD, cm 4.8  1.0
Fig 1.PB, Diastolic blood pressure; SBP, systolic blood pressure; SD, standard
eviation
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December 20121828 AbstractsTable 3. 30-day/in-hospital and late adverse events
Variable
Thoracic endovascular
aortic repair (N47)
Death
30-day death 0 (0%)
Late death 8 (17%)
Aorta-related deaths 0 (0%)
Stroke 1 (2%)
Permanent paraplegia/paraparesis 1 (2%)
Acute renal failure (Cr2.0 and 2 times
baseline Cr)
4 (9%)
New-onset dialysis 2 (4%)
Prolonged mechanical ventilation (48 hours) 3 (6%)
Myocardial ischemia 0 (0%)
Postoperative length of stay (IQR), days 5 (3–7)
Reintervention 13 (28%)
Open 3 (23%)
Endovascular 10 (77%)
Median time to reintervention (IQR), months 4.5 (1.4–8.1)
Median time to follow-up/death (IQR), months 33.4 (13.6–55.2)
Cr, Creatinine; IQR, interquartile range
In Situ Laser Fenestration During Thoracic Endovascular Aortic Re-
pair Is an Effective Method for Left Subclavian Artery
Revascularization
Richard E. Redlinger, Jr, Sadaf S. Ahanchi, Jean M. Panneton. Eastern
Virginia Medical School, Norfolk, Va
Introduction:We have previously described our early experience using
retrograde laser fenestration to revascularize the left subclavian artery (LSA)
during zone II thoracic endovascular aortic repair (TEVAR). This technique
uses a relatively simple intraoperative method of endograft modification to
revascularize aortic branches for a variety of acute thoracic aortic patholo-
gies. The aim of this study is to present our expanded experience and
L
tidterm outcomes of TEVAR with laser fenestration to revascularize the
SA as an alternative to debranching.
Methods: A retrospective review of the electronic medical records was
onducted of all patients who underwent TEVAR with LSA revasculariza-
ion via laser graft fenestration from September 2009 through August 2012.
EVAR was carried out with deployment of a Dacron endograft over the
rifice of the LSA. Through retrograde brachial access, a 0.018-inch guide-
ire was placed at the ostium of the LSA, followed by laser catheter
enestration of the graft. Balloon-expandable covered stents were deployed
hrough the fenestration to traverse the endograft and LSA; the endograft
ortion of the covered stent was flared. Routine postoperative follow-up
maging with computed tomography angiography was performed to assess
or TEVAR and LSA fenestration patency, endoleak, and aneurysm/dissec-
ion exclusion.
Results: TEVAR with laser fenestration was successfully performed in
2 patients (12 men; mean age, 57 years; range, 37-83 years) in an urgent or
mergency setting secondary to unremitting symptoms. Thirteen patients
ad large symptomatic thoracic aortic aneurysms (10 secondary to chronic
issection); four patients had acute symptomatic type B aortic dissection,
nd five patients had intramural hematoma or penetrating aortic ulcer. An
verage of two endografts (range, 1-4) were placed during TEVAR. LSA-
overed stents ranged from 8 to 10mm in diameter.Mean operative time for
EVAR with laser fenestration was 154 65 minutes. The average hospital
ength of stay was 12  7 days. There were no fenestration-related compli-
ations. One patient developed postoperative paraplegia, and one patient
ied of massive hemoptysis in the postoperative period, for an in-hospital
ortality rate of 4.5%. At a mean follow-up of 8 months (range, 1-32
onths), two patients had died (9%) of non–TEVAR-related causes. Follow
p computed tomography angiography imaging demonstrated a 100%
rimary patency for the LSA stents. One patient had an asymptomatic LSA
tent stenosis. Two patients had type II endoleaks from the LSA that
equired reintervention. Both were successfully managed with endovascular
oil embolization. There were no fenestration-related type I or III
ndoleaks.
Conclusions: In situ retrograde laser fenestration is a feasible and
ffective option for LSA revascularization during TEVAR involving a spec-
rum of acute thoracic aortic pathologies. Laser fenestration provides a rapid,
eproducible method of fenestrating the endograft material. The high
echnical success, low fenestration-related morbidity, and excellent midterm
atency support this technique of intraoperative endograft modification.
onger follow-up remains necessary to determine the durability of this
echnique.
